ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California. Show more

Location: 11682 El Camino Real, San Diego, CA, 92130, United States | Website: https://ars-pharma.com | Industry: Biotechnology | Sector: Healthcare


Market Cap

1.665B

52 Wk Range

$8.91 - $18.90

Previous Close

$16.95

Open

$17.12

Volume

1,209,044

Day Range

$16.96 - $17.94

Enterprise Value

1.508B

Cash

275.7M

Avg Qtr Burn

-5.121M

Insider Ownership

16.94%

Institutional Own.

80.28%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.